Herclon 440 mg
With are the optimum choices of the market and maintain a superior collection of medicines for various healthcare needs. Our Herclon 440mg is largely used in essential treatments and are supplied to several hospitals and medicine stores.
Specifications :
-
Trastuzumab, a monoclonal antibody, has action directed against a cell surface protein produced by human epidermal growth factor receptor 2 (HER2). It inhibits proliferation of tumour cells that overexpress HER2 e.g. in 1/3 of breast cancer. Distribution: Vd: 44 mL/kg; unlikely to cross intact blood brain barrier
-
Excretion : Half-life ranges from 5.8 to 28.5 days after admin of the recommended doses
|